Affyimmune Therapeutics, Inc., a Natick-based clinical stage biotech company specializing in solid cancer treatment, has named biotech entrepreneur and executive Robert Forrester to its board of directors.
A Sept. 22 study released by Worcester-based nonprofit Wake Up Narcolepsy has found physicians in and around Boston may know less about diagnosing narcolepsy than they think they do.
Marlborough-based medical technology company Hologic’s second annual Global Women’s Health Index reveals a lack of progress in women’s health care indicators worldwide.
The board of directors of Blue Cross Blue Shield of Massachusetts has named its first female CEO, Sarah Iselin, the Boston-based health insurer announced at the end of August.
While demand for affordable housing outstrips available units and rents continue to rise, homelessness rates in Central Massachusetts are skyrocketing.Â
Scientists at UMass Chan Medical School in Worcester have developed a web application which will allow researchers and public health officials to track variants and clinical information about COVID-19 in Central Massachusetts, the medical school said on Thursday.